Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan, NS Yacovzada… - European Heart …, 2023 - academic.oup.com
Aims The advantages of direct oral anticoagulants (DOACs) over warfarin are well
established in atrial fibrillation (AF) patients, however, studies that can guide the selection …

Head-to-head Efficacy and Safety of Rivaroxaban, Apixaban and Dabigatran in an Observational Nationwide Targeted Trial.

Y Talmor-Barkan, NS Yacovzada… - European Heart …, 2022 - europepmc.org
Aims The advantages of direct oral anticoagulants (DOACs) over warfarin are well
established in atrial fibrillation (AF) patients, however, studies that can guide in the selection …

Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan, NS Yacovzada… - European heart …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims The advantages of direct oral anticoagulants (DOACs) over warfarin are well
established in atrial fibrillation (AF) patients, however, studies that can guide the selection …

Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan… - European …, 2023 - weizmann.esploro.exlibrisgroup.com
The advantages of direct oral anticoagulants (DOACs) over warfarin are well established in
atrial fibrillation (AF) patients, however, studies that can guide the selection between …

Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan, NS Yacovzada… - European heart …, 2023 - weizmann.elsevierpure.com
The advantages of direct oral anticoagulants (DOACs) over warfarin are well established in
atrial fibrillation (AF) patients, however, studies that can guide the selection between …

Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan… - European …, 2023 - … .esploro.exlibrisgroup.com
The advantages of direct oral anticoagulants (DOACs) over warfarin are well established in
atrial fibrillation (AF) patients, however, studies that can guide the selection between …

Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan, NS Yacovzada… - European Heart …, 2023 - academic.oup.com
Aims The advantages of direct oral anticoagulants (DOACs) over warfarin are well
established in atrial fibrillation (AF) patients, however, studies that can guide the selection …

Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan, NS Yacovzada… - European Heart …, 2023 - search.proquest.com
Aims The advantages of direct oral anticoagulants (DOACs) over warfarin are well
established in atrial fibrillation (AF) patients, however, studies that can guide the selection …

Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial

Y Talmor-Barkan… - European …, 2023 - … .esploro.exlibrisgroup.com
The advantages of direct oral anticoagulants (DOACs) over warfarin are well established in
atrial fibrillation (AF) patients, however, studies that can guide the selection between …